What Is MEDDIC? The Sales Qualification Framework Explained

MEDDIC is a six-part qualification framework that tells you exactly how likely a deal is to close — and what's missing if it isn't. Built for complex B2B sales cycles, it forces reps to answer six hard questions before a deal moves forward: what's the measurable impact, who controls the budget, how does the company decide, what's the process, what's the pain, and who internally is selling for you. If you can't answer all six, the deal is at risk.

What does MEDDIC stand for?

MEDDIC is an acronym for six qualification criteria: Metrics, Economic Buyer, Decision Criteria, Decision Process, Identify Pain, and Champion. Each letter represents a question your team must be able to answer before treating a deal as real pipeline.

Metrics

What is the quantifiable impact of solving this problem? This means actual numbers — reduction in churn rate by 15%, time saved per rep per week, revenue at risk per quarter. If the prospect can't articulate a number and you can't help them build one, the business case won't survive a CFO review. Metrics are what turn emotional buy-in into budget approval.

Economic Buyer

Who has the authority to sign the deal? Not the champion, not the committee — the single person who can say yes and release funds. Many deals stall because reps spend months with an enthusiastic champion who has no budget authority. You need to have a conversation with the economic buyer directly, or at minimum understand their priorities through your champion.

Decision Criteria

What criteria will be used to evaluate solutions? This includes technical requirements, integration specs, security certifications, vendor track record, and price. If you don't know what they're scoring you on, you can't influence how they score you. Your job here is to understand the criteria early and, where possible, shape them in your favour.

Decision Process

What are the steps the prospect will take to reach a decision? Who signs off at each stage? Is legal involved? Does it need board approval? Decision process maps the road to closed-won, including all the tollgates that can kill a deal after a verbal yes. Reps who skip this question are regularly blindsided by "we need three more months" at the finish line.

Identify Pain

What is the specific business problem driving urgency? Not a vague dissatisfaction — a concrete, costly pain that has a name and a number attached to it. Pain is what creates urgency. Without identified pain, there's no reason to buy now rather than next quarter or never. The best reps surface pain that the prospect hasn't fully articulated to themselves yet.

Champion

Who inside the organisation is actively selling for you when you're not in the room? A champion is not just someone who likes your product. They have influence, they benefit personally from the deal, and they are willing to spend political capital to make it happen. Without a champion, every deal depends entirely on you — which is a losing position in enterprise sales.

Where did MEDDIC come from?

MEDDIC was developed at PTC (Parametric Technology Corporation) in the early 1990s by Dick Dunkel, under the leadership of John McMahon. PTC was selling complex engineering software into large manufacturing companies — long cycles, multiple stakeholders, significant deal sizes. The framework gave PTC's sales team a shared language for qualifying deals and a consistent method for forecasting.

"MEDDIC gave us a common language across the entire sales organisation. For the first time, when a rep said a deal was at 80%, every manager knew exactly what that meant and what was still missing."

— John McMahon, former SVP of Sales, PTC, as quoted in The Qualified Sales Leader

The results were significant. PTC grew from approximately $300 million in annual revenue to over $1 billion during the period when MEDDIC was embedded across the sales organisation. The framework has since spread through the enterprise software world, largely carried by PTC alumni who took it to companies like Salesforce, MongoDB, and Hubspot.

How is MEDDIC different from other qualification frameworks?

The most common alternative frameworks are BANT (Budget, Authority, Need, Timeline) and SPIN Selling. MEDDIC is more rigorous than both — and more appropriate for complex, multi-stakeholder deals.

BANT was developed by IBM in the 1950s for transactional sales. It asks whether budget exists, who has authority, whether there's a need, and what the timeline is. In modern enterprise SaaS, these questions are necessary but nowhere near sufficient. Budget is rarely pre-allocated for new software; authority is distributed across committees; need is often undefined until you surface it. BANT gives you four data points. MEDDIC gives you a deal map.

SPIN Selling, developed by Neil Rackham at Huthwaite, is primarily a questioning methodology — Situation, Problem, Implication, Need-Payoff. It's excellent for discovery but doesn't give reps a qualification checklist to grade pipeline health. MEDDIC and SPIN complement each other: use SPIN in discovery calls to surface the pain and metrics, then score the deal against MEDDIC criteria.

According to Gartner's research on B2B buying behaviour, the average enterprise buying group now involves 6–10 decision-makers. BANT was designed for single-buyer decisions. MEDDIC's Economic Buyer, Decision Process, and Champion criteria exist precisely because modern deals don't work that way.

When should you use the MEDDIC framework?

MEDDIC is designed for complex enterprise sales — not every deal. The right fit is: ACV above $25,000, sales cycle longer than 60 days, more than two stakeholders involved, and a solution that requires organisational change to implement. Below that threshold, MEDDIC adds overhead without proportional return.

The framework is most valuable at two specific moments in the sales cycle. First, during early qualification — to decide whether a deal is worth pursuing at all. Second, during deal reviews — to identify exactly what's missing and what needs to happen before forecast can move. A rep who walks into a deal review with all six MEDDIC criteria answered has a fundamentally different conversation than one who doesn't.

Teams prospecting into accounts that already use a competitor are in an especially strong position to apply MEDDIC early. If you know a company is already paying for a competing solution, Metrics and Pain become much easier to surface — they've already validated the need and made a business case internally. Tools like Stealery let you build lists of companies currently using a specific competitor, which means you can enter those MEDDIC conversations with context most reps don't have: you know the incumbent, the likely pain points of switching, and the economic frame they've already accepted.

What is MEDDICC and how is it different from MEDDIC?

MEDDICC adds a seventh criterion: Competition. This forces reps to explicitly document who else is being evaluated, what the competitive strengths and weaknesses are, and whether the prospect has shared their decision criteria with competing vendors. It's a natural extension of the original framework and is now more commonly used in enterprise SaaS than the original six-letter acronym.

Some organisations use MEDDPICC, which also adds Paper Process — the legal, procurement, and contract review steps that happen after a verbal yes. In deals where legal and procurement can add 4–8 weeks of delay, ignoring paper process is how Q3 deals become Q4 deals. If your company sells into regulated industries, financial services, healthcare, or government, MEDDPICC is the appropriate version to use.

How do you implement MEDDIC in your sales process?

Implementation fails most often because MEDDIC gets treated as a form to fill out rather than a qualification discipline to build. Three things determine whether it sticks.

Embed it in your CRM, not a separate doc

Each MEDDIC criterion should be a field in your CRM opportunity record. If it's not in the CRM, it doesn't exist for forecasting or deal review purposes. Many teams use a simple scoring system: each criterion answered scores one point, and deals below four out of six don't move to the next pipeline stage. This creates a consistent definition of "qualified" across the team.

Make it a deal review language, not a training topic

The fastest way to make MEDDIC real is to run every deal review using its criteria. When a rep says a deal is 80% likely to close, the manager asks: "Who's the champion? Have you met the economic buyer? What's their decision process?" If reps know they'll be asked those questions, they'll make sure they have answers. MEDDIC adoption is a management behaviour problem as much as a rep training problem.

Start with the two hardest criteria

Champion and Economic Buyer are the most commonly missing and the most predictive of deal outcome. Salesforce's own research on sales qualification has consistently found that deals without executive engagement close at dramatically lower rates. If you focus your team on one thing first, it's making sure they have a named champion with influence and that they've had at least one conversation with the economic buyer.

What are the most common mistakes when using MEDDIC?

The most common mistake is confusing a sponsor with a champion. A sponsor likes your product and will take your meetings. A champion will fight for you internally, share information they're not supposed to share, and push back on procurement when they're stalling. Most deals have a sponsor. The ones that close have a champion. Ask directly: "If I'm not in the room and your leadership asks why they should go with us, what do you say?" The answer tells you whether you have a champion or just a friendly contact.

The second mistake is treating MEDDIC as a one-time assessment at deal open rather than a live document. Champion status can change when someone leaves. Decision criteria can shift after a board meeting. Economic buyer can change in a reorg. MEDDIC should be re-verified at every major stage transition, not completed once and forgotten.

The third mistake is skipping Metrics because the prospect pushes back. Prospects often resist putting a number on pain because it creates accountability on their side. But without metrics, the business case can't be built, ROI can't be calculated, and the economic buyer has nothing to approve. The discomfort of building metrics together is part of the qualification process — it separates prospects who are serious from those who are exploring.